Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Outcome of Vinpocetine in Diabetic Nephropathy
Sponsor: Ain Shams University
Summary
The goal of this controlled, randomized, clinical trial is to evaluate the effect of vinpocetine on clinical outcomes on the diabetic nephropathy patients. The following will be evaluated; anthropometrics, kidney functions, glucose panel, lipid panel, ICAM-1, quality of life. Participants will receive either vinpocetine or placebo, twice daily for 3 months.
Official title: The Effect of Vinpocetine on the Clinical Outcome of Patients With Diabetic Nephropathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
64
Start Date
2024-07-10
Completion Date
2025-06-01
Last Updated
2024-07-11
Healthy Volunteers
No
Interventions
Vinpocetine
Vinca derivative of apovincamine, phosphodiestrase 1 inhibitor, sodium-gated voltage channel
Standard Therapy
Anti-hypertensive and anti-diabetic medications according to the the institution's protocol
Placebo
Starch-filled capsules, matching those of the intervention
Locations (2)
Ain Shams University Hospital
Cairo, Abbasseia, Egypt
Ain Shams Hospitals
Cairo, Abbasseya, Egypt